AACR-Conquer Cancer, the ASCO Foundation Young Investigator Award for Translational Cancer Research Grant
American Association for Cancer Research
Funding Amount
US $50,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- You must be a member of this organization to apply for this award - become a member.
Overview
The AACR-Conquer Cancer, the ASCO Foundation Young Investigator Award for Translational Cancer Research supports early-career physician-scientists transitioning from fellowship to faculty roles. This award provides $50,000 for one year to fund research in translational oncology, covering essential expenses such as supplies and publication fees. It aims to foster innovative research that can lead to impactful cancer treatments, promoting excellence in the field of oncology.
The AACR-Conquer Cancer®, the ASCO Foundation Young Investigator Award for Translational Cancer Research provides funding to promising investigators to encourage and promote quality research in translational oncology. The purpose of this jointly-supported award is to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to translational cancer research.
The award provides $50,000 over one year for expenses related to the research project. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.
Eligibility
You must be a member of this organization to apply for this award - become a member.
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 11, 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 8, 2027
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
July 5, 2029
Ready to apply for AACR-Conquer Cancer, the ASCO Foundation Young Investigator Award for Translational Cancer Research Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found AACR-Conquer Cancer, the ASCO Foundation Young Investigator Award for Translational Cancer Research Grant. Now let's win it.